Catalyst Wire Dossier Catalyst Wire Dossier

robatumumab

robatumumab · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for robatumumab, covering 2015-12-11 to 2016-02-10. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) [Phase 1]

See pricing